Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Experience and Real-world Safety and Effectiveness of Envafolimab: Observational, Non-interventional Outcomes From a Multi-country Named Patient Access Program (ENCOMPASS STUDY)

NCT07562347 is registered in ClinicalTrials.gov with IR INNOVATE RESEARCH PRIVATE LIMITED as lead sponsor.

NCT NCT07562347
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07562347 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Experience and Real-world Safety and Effectiveness of Envafolimab: Observational, Non-interventional Outcomes From a Multi-country Named Patient Access Program (ENCOMPASS STUDY)
Lead sponsor
IR INNOVATE RESEARCH PRIVATE LIMITED
Phase
Observational
Overall status
Not yet recruiting
Start date
May 31, 2026
Completion date
October 31, 2027
Enrollment
120 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumor